Hot Topics: Health Regulation & Law

Blog Posts (85)

February 15, 2017

The National Academy of Sciences Expands its Approval for Gene Editing

by Keisha Ray, Ph.D.

This week the National Academy of Sciences (NAS) released a report giving their support for altering heritable genes when previously the NAS only supported altering uninheritable genes.…

February 13, 2017

The Death of Aid-in-Dying in DC

by Craig Klugman, Ph.D.

I recently gave a talk to a local chapter of a national physicians’ health care group where I was talking about what end of life could look like under a single payer health care system.…

January 30, 2017

Bioethics and the Problem of Silent Neutrality in the age of Trump

by Craig Klugman, Ph.D.

One of the most contentious of all issues in bioethics has been whether as a profession, we should take a stand against issues.…

January 24, 2017

Can Science Survive in a Communications Blackout: Restricting Speech Violates Scientific Ethics

by Craig Klugman, Ph.D.

That good ethics begins with good facts is an oft-heard mantra and was my first lesson when I began conducting clinical ethics consults 20 years ago.…

January 17, 2017

The Future of Health Insurance May Look A Lot Like Our Past

by Craig Klugman, Ph.D.

This week marks the transition of power from President Obama to President-elect Trump. One issue that has been high on Trump’s list of policy changes is a repeal and replace of the Affordable Care Act (a.k.a.…

January 10, 2017

Be Wary What You Research: You Might Get Sued

by Craig M. Klugman, Ph.D.

Peter Cohen, Clayton Bloszies, Caleb Yee and Roy Gerona published an article in the journal Drug Testing and Analysis in April 2015 explaining the results of their testing of supplements.…

January 4, 2017

Last Days of the ACA

by Craig M. Klugman, Ph.D.

Politicians are notorious for making campaign promises and then not carrying them out. With the beginning of the 115th Congress, the GOP has doubled-down on its promise to repeal the Affordable Care Act (aka “Obamacare”).…

January 2, 2017

The Year in Bioethics That Was - 2016

by Craig Klugman, Ph.D.

Happy New Year. As has become a tradition at the bioethics.net blogs, the ending of one year and beginning of another is a time for reflection, for reviewing the year that has passed and planning for the year to come.…

December 1, 2016

Bioethics Under Attack: Analysis Is Seen As Threat

by Craig Klugman, Ph.D.

A September article in Bioethics by Julian Savulescu and Udo Schuklenk has lit a fire under the Christian media.…

November 9, 2016

President Trump & A Republican Congress: What Might It Mean?

by Craig Klugman, Ph.D.

In a 2000 episode of The Simpsons, a flash forward shows Lisa being elected the first heterosexual female U.S.…

View More Blog Entries

Published Articles (15)

American Journal of Bioethics: Volume 17 Issue 3 - Mar 2017

The Precautionary Principle and the Tolerability of Blood Transfusion Risks Koen Kramer, Hans L. Zaaijer & Marcel F. Verweij

AJOB Primary Research: Volume 8 Issue 1 - Feb 2017

Morals or markets? Regulating assisted reproductive technologies as morality or economic policies in the states Erin Heidt-Forsythe

AJOB Primary Research: Volume 8 Issue 1 - Feb 2017

Problematic protocols: An overview of medical research protocols not approved by the LUMC medical ethics review committee Derek Gideon Tersmette & Dirk Peter Engberts

American Journal of Bioethics: Volume 16 Issue 12 - Dec 2016

Does Lack of “Genetic-Relative Family Health History” Represent a Potentially Avoidable Health Disparity for Adoptees? Thomas May, Kimberly A. Strong, Kaija L. Zusevics, Jessica Jeruzal, Michael H. Farrell, Alison LaPean Kirschner, Arthur R. Derse, James P. Evans & Harold D. Grotevant

American Journal of Bioethics: Volume 16 Issue 11 - Nov 2016

The Ethics of Organ Donor Registration Policies: Nudges and Respect for Autonomy Douglas MacKay & Alexandra Robinson

American Journal of Bioethics: Volume 16 Issue 11 - Nov 2016

Autonomy by Default Cass R. Sunstein

AJOB Primary Research: Volume 7 Issue 3 - Jul 2016

Ethical challenges in designing and implementing health systems research: Experiences from the field Adnan Hyder & Carleigh Krubiner

American Journal of Bioethics: Volume 16 Issue 2 - Feb 2016

Fetal Risks, Relative Risks, and Relatives' Risks Howard Minkoff & Mary Faith Marshall

American Journal of Bioethics: Volume 16 Issue 2 - Feb 2016

Restricting Choices of Childbearing Women Bela Fishbeyn

American Journal of Bioethics: Volume 15 Issue 8 - Aug 2015

The Texas Advanced Directive Law: Unfinished Business Michael Kapottos & Stuart Youngner

News (182)

February 16, 2017 9:00 am

Speedy drug approvals are risky, but drug companies have another idea that's just terrible (Los Angeles Times)

As with Trump’s proposed elimination of consumer safeguards, environmental-protection measures and financial reforms, the reality is that if his administration proceeds with a wholesale deregulation of the drug industry, the public will be largely undefended against the aggressive and potentially dangerous predations of multibillion-dollar conglomerates.

February 6, 2017 9:00 am

Will the Trump presidency mean the end of FDA drug regulation? (Los Angeles Times)

Donald Trump will be coming into office waving the banner of deregulation. While most of the speculation about his plans has focused on the financial industry and the possibility of eviscerating Dodd-Frank reforms, keep your eyes on the Food and Drug Administration. In a Trump administration the agency, figuratively speaking, will have a big bull’s-eye on its back.

January 25, 2017 9:00 am

We spoke with the man who could lead the world's top health organization (Business Insider)

The WHO lost a lot of trust in the aftermath of the 2014 Ebola outbreak in West Africa. Nabarro said his hope is to make sure that doesn’t happen again.

January 24, 2017 9:00 am

With executive order, Trump tosses a ‘bomb’ into fragile health insurance markets (Washington Post)

The practical implications of Trump’s action on Friday are harder to decipher. Its language instructs all federal agencies to “waive, defer, grant ­exemptions from or delay” any part of the law that imposes a financial or regulatory burden on those affected by it. That would cover consumers, doctors, hospitals and other providers, as well as insurers and drug companies.

January 20, 2017 9:00 am

How Science Is Helping Us Understand Gender (National Geographic)

A “neutral space” is a hard thing for a teenager to carve out: Biology has a habit of declaring itself eventually. Sometimes, though, biology can be put on hold for a while with puberty-blocking drugs that can buy time for gender-questioning children.

January 9, 2017 9:00 am

Fact-checking Congress’s fetal tissue report (Science)

They interviewed senior physicians from Planned Parenthood, who spoke bluntly about their provision of fetal tissue from legal abortions for medical research

January 5, 2017 9:00 am

After Backlash, Including From Trump, House GOP Drops Weakening Of Ethics Office (NPR)

House Republicans have reversed themselves and restored the current rules of the Office of Congressional Ethics

December 23, 2016 9:00 am

Abortion Is Found to Have Little Effect on Women’s Mental Health (The New York Times)

Some states require women seeking abortions to be counseled that they might develop mental health problems. Now a new study, considered to be the most rigorous to look at the question in the United States, undermines that claim.

December 14, 2016 9:00 am

Endgame in Aleppo, the most decisive battle yet in Syria’s war (Washington Post)

Aleppo would go down in history as one of the great failures of the international community to halt human rights abuses.

December 5, 2016 9:00 am

UK moves closer to allowing ‘three-parent’ babies (Nature)

United Kingdom may soon become the first country to explicitly permit the birth of children from embryos modified to contain three people’s DNA.

View More News Items